Go Pro
→ The end may be near for these iconic stocks (From Chaikin Analytics) (Ad)tc pixel Free SUN Stock Alerts

Surgical Innovations Group (SUN) Competitors

Surgical Innovations Group logo
GBX 0.45 -0.05 (-10.00%)
As of 08/7/2026 09:58 AM Eastern
Compare

SUN vs. BRY, MXC, NOG, HNR, and WRES

Should you buy Surgical Innovations Group stock or one of its competitors? MarketBeat compares Surgical Innovations Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Surgical Innovations Group include Brady (BRY), Argent BioPharma (MXC), Nostrum Oil & Gas (NOG), Highlands Natural Resources (HNR), and W Resources (WRES).

How does Surgical Innovations Group compare to Brady?

Brady (LON:BRY) and Surgical Innovations Group (LON:SUN) are related small-cap companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, institutional ownership, earnings, media sentiment, profitability and risk.

2.8% of Surgical Innovations Group shares are owned by institutional investors. 22.2% of Surgical Innovations Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Surgical Innovations Group is trading at a lower price-to-earnings ratio than Brady, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Brady£22.16M0.00N/A-£3.70N/A
Surgical Innovations Group£11.60M0.36N/A-£0.10N/A

Brady has a net margin of 0.00% compared to Surgical Innovations Group's net margin of -4.96%. Brady's return on equity of 0.00% beat Surgical Innovations Group's return on equity.

Company Net Margins Return on Equity Return on Assets
BradyN/A N/A N/A
Surgical Innovations Group -4.96%-6.04%-3.03%

In the previous week, Surgical Innovations Group had 1 more articles in the media than Brady. MarketBeat recorded 1 mentions for Surgical Innovations Group and 0 mentions for Brady. Brady's average media sentiment score of 0.00 equaled Surgical Innovations Group'saverage media sentiment score.

Company Overall Sentiment
Brady Neutral
Surgical Innovations Group Neutral

Summary

Surgical Innovations Group beats Brady on 5 of the 9 factors compared between the two stocks.

How does Surgical Innovations Group compare to Argent BioPharma?

Argent BioPharma (LON:MXC) and Surgical Innovations Group (LON:SUN) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, profitability, earnings, risk, media sentiment, institutional ownership and valuation.

Argent BioPharma has a beta of 1.03, indicating that its share price is 3% more volatile than the broader market. Comparatively, Surgical Innovations Group has a beta of 0.65, indicating that its share price is 35% less volatile than the broader market.

1.2% of Argent BioPharma shares are held by institutional investors. Comparatively, 2.8% of Surgical Innovations Group shares are held by institutional investors. 8.2% of Argent BioPharma shares are held by insiders. Comparatively, 22.2% of Surgical Innovations Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, Surgical Innovations Group had 1 more articles in the media than Argent BioPharma. MarketBeat recorded 1 mentions for Surgical Innovations Group and 0 mentions for Argent BioPharma. Argent BioPharma's average media sentiment score of 0.00 equaled Surgical Innovations Group'saverage media sentiment score.

Company Overall Sentiment
Argent BioPharma Neutral
Surgical Innovations Group Neutral

Argent BioPharma has a net margin of 0.00% compared to Surgical Innovations Group's net margin of -4.96%. Argent BioPharma's return on equity of 0.00% beat Surgical Innovations Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Argent BioPharmaN/A N/A -58.96%
Surgical Innovations Group -4.96%-6.04%-3.03%

Surgical Innovations Group has higher revenue and earnings than Argent BioPharma. Surgical Innovations Group is trading at a lower price-to-earnings ratio than Argent BioPharma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Argent BioPharma£1.32M0.00-£17.02M-£1.66N/A
Surgical Innovations Group£11.60M0.36N/A-£0.10N/A

Summary

Surgical Innovations Group beats Argent BioPharma on 7 of the 10 factors compared between the two stocks.

How does Surgical Innovations Group compare to Nostrum Oil & Gas?

Surgical Innovations Group (LON:SUN) and Nostrum Oil & Gas (LON:NOG) are related small-cap companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, media sentiment, risk, dividends, profitability, analyst recommendations, institutional ownership and valuation.

Surgical Innovations Group has a net margin of -4.96% compared to Nostrum Oil & Gas' net margin of -184.95%. Nostrum Oil & Gas' return on equity of 88.74% beat Surgical Innovations Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Surgical Innovations Group-4.96% -6.04% -3.03%
Nostrum Oil & Gas -184.95%88.74%1.53%

Surgical Innovations Group has a beta of 0.65, indicating that its share price is 35% less volatile than the broader market. Comparatively, Nostrum Oil & Gas has a beta of 0.751, indicating that its share price is 25% less volatile than the broader market.

2.8% of Surgical Innovations Group shares are owned by institutional investors. Comparatively, 9.7% of Nostrum Oil & Gas shares are owned by institutional investors. 22.2% of Surgical Innovations Group shares are owned by company insiders. Comparatively, 44.0% of Nostrum Oil & Gas shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Nostrum Oil & Gas has a consensus target price of GBX 4, indicating a potential upside of 11.11%. Given Nostrum Oil & Gas' stronger consensus rating and higher probable upside, analysts clearly believe Nostrum Oil & Gas is more favorable than Surgical Innovations Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Surgical Innovations Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Nostrum Oil & Gas
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Surgical Innovations Group has higher earnings, but lower revenue than Nostrum Oil & Gas. Surgical Innovations Group is trading at a lower price-to-earnings ratio than Nostrum Oil & Gas, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Surgical Innovations Group£11.60M0.36N/A-£0.10N/A
Nostrum Oil & Gas£120.77M0.05-£121.71M-£134.00N/A

In the previous week, Surgical Innovations Group had 1 more articles in the media than Nostrum Oil & Gas. MarketBeat recorded 1 mentions for Surgical Innovations Group and 0 mentions for Nostrum Oil & Gas. Surgical Innovations Group's average media sentiment score of 0.00 equaled Nostrum Oil & Gas'average media sentiment score.

Company Overall Sentiment
Surgical Innovations Group Neutral
Nostrum Oil & Gas Neutral

Summary

Nostrum Oil & Gas beats Surgical Innovations Group on 9 of the 13 factors compared between the two stocks.

How does Surgical Innovations Group compare to Highlands Natural Resources?

Highlands Natural Resources (LON:HNR) and Surgical Innovations Group (LON:SUN) are related small-cap companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, valuation, institutional ownership, risk, dividends, earnings and analyst recommendations.

In the previous week, Surgical Innovations Group had 1 more articles in the media than Highlands Natural Resources. MarketBeat recorded 1 mentions for Surgical Innovations Group and 0 mentions for Highlands Natural Resources. Highlands Natural Resources' average media sentiment score of 0.00 equaled Surgical Innovations Group'saverage media sentiment score.

Company Overall Sentiment
Highlands Natural Resources Neutral
Surgical Innovations Group Neutral

Highlands Natural Resources has a net margin of 0.00% compared to Surgical Innovations Group's net margin of -4.96%. Highlands Natural Resources' return on equity of 0.00% beat Surgical Innovations Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Highlands Natural ResourcesN/A N/A N/A
Surgical Innovations Group -4.96%-6.04%-3.03%

2.8% of Surgical Innovations Group shares are held by institutional investors. 22.2% of Surgical Innovations Group shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Surgical Innovations Group is trading at a lower price-to-earnings ratio than Highlands Natural Resources, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Highlands Natural Resources£1.02M0.00N/A-£4.90N/A
Surgical Innovations Group£11.60M0.36N/A-£0.10N/A

Summary

Surgical Innovations Group beats Highlands Natural Resources on 5 of the 9 factors compared between the two stocks.

How does Surgical Innovations Group compare to W Resources?

Surgical Innovations Group (LON:SUN) and W Resources (LON:WRES) are related small-cap companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, earnings, dividends, institutional ownership, media sentiment, risk and profitability.

Surgical Innovations Group has higher revenue and earnings than W Resources. Surgical Innovations Group is trading at a lower price-to-earnings ratio than W Resources, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Surgical Innovations Group£11.60M0.36N/A-£0.10N/A
W Resources£3.47M0.00-£6.06M-£6.10N/A

2.8% of Surgical Innovations Group shares are owned by institutional investors. Comparatively, 4.6% of W Resources shares are owned by institutional investors. 22.2% of Surgical Innovations Group shares are owned by insiders. Comparatively, 28.0% of W Resources shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Surgical Innovations Group had 1 more articles in the media than W Resources. MarketBeat recorded 1 mentions for Surgical Innovations Group and 0 mentions for W Resources. Surgical Innovations Group's average media sentiment score of 0.00 equaled W Resources'average media sentiment score.

Company Overall Sentiment
Surgical Innovations Group Neutral
W Resources Neutral

Surgical Innovations Group has a beta of 0.65, suggesting that its share price is 35% less volatile than the broader market. Comparatively, W Resources has a beta of 1.05, suggesting that its share price is 5% more volatile than the broader market.

Surgical Innovations Group has a net margin of -4.96% compared to W Resources' net margin of -174.96%. Surgical Innovations Group's return on equity of -6.04% beat W Resources' return on equity.

Company Net Margins Return on Equity Return on Assets
Surgical Innovations Group-4.96% -6.04% -3.03%
W Resources -174.96%-33.02%-2.04%

Summary

Surgical Innovations Group and W Resources tied by winning 5 of the 10 factors compared between the two stocks.

Get Surgical Innovations Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for SUN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SUN vs. The Competition

Export
MetricSurgical Innovations GroupHealthcare Equipment & Supplies IndustryHealthcare SectorLON Exchange
Market Cap£4.66M£5.80B£7.01B£2.88B
Dividend Yield2.63%1.78%2.58%6.12%
P/E Ratio-4.5024.26271.11368.42
Price / Sales0.3662.04595.5983,672.22
Price / Cash5.0333.1071.8127.89
Price / Book0.455.7013.257.20
Net IncomeN/A£148.58M£3.45B£5.89B
7 Day Performance-10.89%4.75%4.67%1.90%
1 Month Performance-0.44%0.71%-1.28%2.42%
1 Year Performance-31.61%4.93%77.33%74.54%

Surgical Innovations Group Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SUN
Surgical Innovations Group
N/AGBX 0.45
-10.0%		N/A-31.6%£4.66M£11.60MN/A80
BRY
Brady
N/AN/AN/AN/A£15.17M£22.16MN/A1,370
MXC
Argent BioPharma
N/AN/AN/AN/A£9.65M£1.32MN/A5
NOG
Nostrum Oil & Gas
0.6755 of 5 stars		GBX 4.39
+9.8%		GBX 4
-8.9%		-9.1%£7.24M£120.77MN/A30
HNR
Highlands Natural Resources
N/AN/AN/AN/A£6.95M£1.02MN/A16

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:SUN) was last updated on 8/9/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel